Showing results (101-110 of 216) with videos related to
Sort By:
Pageof 22
British Journal of Haematology|February 6, 2016
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 monthsMatthew A Lunning, Jocelyn C Migliacci, Patrick Hilden, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Sustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodiesParastoo B Dahi, Jonathan Barone, Sean M Devlin, et al.Transplantation and Cellular Therapy|May 15, 2021
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected GraftsReuben P Jacob, Jessica Flynn, Sean M Devlin, et al.Leukemia & Lymphoma|June 11, 2014
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplantIzaskun Ceberio, Sean M Devlin, Craig Sauter, et al.British Journal of Haematology|June 27, 2015
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer CenterJustin M Watts, Ashwin Kishtagari, Meier Hsu, et al.Leukemia Research|August 30, 2016
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemiaJustin M Watts, Bogdan Dumitriu, Patrick Hilden, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple MyelomaEric Smith, Sean M Devlin, Satyajit Kosuri, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2020
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood TransplantationVictoria Gutgarts, Insara Jaffer Sathick, Junting Zheng, et al.Bone Marrow Transplantation|August 24, 2018
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer centerRichard J Lin, Theresa A Elko, Miguel-Angel Perales, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2018
Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based TherapyMark B Geyer, Isabelle Rivière, Brigitte Sénéchal, et al.Pageof 22